Recently Reches et al. reported that nectin4 is also a ligand for TIGIT and their interaction inhibits NK cell function, while anti-nectin4 blocking antibodies induced enhanced tumour killing in vitro and in vivo [66]. The gene discussed is NECTIN4; the disease is neoplasm.